The cytoskeleton actin binding protein filamin A impairs both IGF2 mitogenic effects and the efficacy of IGF1R inhibitors in adrenocortical cancer cells
Rosa Catalano(University of Milan), Erika Peverelli(University of Milan)
Cited by 17
Related Papers
Dopamine receptor type 2 (<scp>DRD2</scp>) and somatostatin receptor type 2 (<scp>SSTR2</scp>) agonists are effective in inhibiting proliferation of progenitor/stem‐like cells isolated from nonfunctioning pituitary tumors
|International Journal of Cancer|2017|60
Cytoskeleton Protein Filamin A Is Required for Efficient Somatostatin Receptor Type 2 Internalization and Recycling through Rab5 and Rab4 Sorting Endosomes in Tumor Somatotroph Cells
|Neuroendocrinology|2019|19
TMPRSS2 Expression and Activity Modulation by Sex-Related Hormones in Lung Calu-3 Cells: Impact on Gender-Specific SARS-CoV-2 Infection
|Frontiers in Endocrinology|2022|8
Therapeutic potential of targeting the FLNA‐regulated Wee1 kinase in adrenocortical carcinomas
|International Journal of Cancer|2024|6
Emerging role of IGF1R and IR expression and localisation in adrenocortical carcinomas
|Cell Communication and Signaling|2025|3